Английский Українська
  • Главная
  • Полезные ссылки
  • О журнале
  • Авторам
  • Редакционная коллегия

    •
    Статья
    Мир Медицины и Биологии / №2(49), 2015 #1 / ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ РНК-ИНТЕРФЕРЕНЦИИ В ЛЕЧЕНИИ ВИЧ-ИНФЕКЦИИ
    Черникова Л. И., Коваленко Н. И.

    ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ РНК-ИНТЕРФЕРЕНЦИИ В ЛЕЧЕНИИ ВИЧ-ИНФЕКЦИИ

    Об авторе: Черникова Л. И., Коваленко Н. И.
    Рубрика ОБЗОРЫ ЛИТЕРАТУРЫ
    Тип статьи Обзорная статья
    Аннотация Проведен анализ результатов исследований применения системы РНК-интерференции для подавления репродукции ВИЧ в чувствительных клетках на разных этапах жизненного цикла вируса и для блокирования ко-рецепторов CCR5 клеток человека.
    Ключевые слова генотерапия, РНК-интерференция, ВИЧ-инфекция
    Список цитируемой литературы
    • VІL-іnfekcіja v Ukraїnі. Іnformacіjnij bjuleten'. – Kiїv, - 2014. – № 41. – 95 s.
    • Pat. № 2425150, RU, MPK C12N15/63, A61K39/21. /Institut molekuljarnoj biologii im. V.A. Jengel'gardta RAN RF, Churikov N.A., Kretova O.V. – Z. № 2009142859/10; zajavl. 23.11.2009; opubl. 27.07.2011. Kassetnaja geneticheskaja konstrukcija, jekspressirujushhaja tri biologicheski aktivnye siRNA, jeffektivno atakujushhie transkripty virusa immunodeficita cheloveka i gena CCR5 s pomoshh'ju RNK-interferencii.
    • Pukіsh N. S. Analіz molekuljarnih osoblivostej ukraїns'kih іzoljatіv VІL-1 / N. S. Pukіsh, A. M. Shherbіns'ka, N. O. Babіj [ta іn.] // Bіopolіmeri і klіtini. – 2009. – T. 25, № 1. – S. 50-55.
    • Poljakov A. N. Rezistentnost' virusa immunodeficita cheloveka k antiretrovirusnym preparatam / A. N. Poljakov, V. V. Rassohin // VICh-infekcija i immunosupressija. – 2010. – T. 2, № 2. – S. 48-57.
    • An D.S. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates / D.S. An, R.E. Donahue, M. Kamata [et al.] // Proc. Nat. Acad. Sci. USA. – 2007. – Vol. 104. – P. 13110–13115.
    • Blick G. Protected T-cells persist and proliferate in HIV gene therapy study / G. Blick // 21st Conference on Retroviruses and Opportunistic Infections (CROI). – Abstract 91LB. – Boston, - 2014.
    • Cheng K., Advanced delivery and therapeutic applications of RNAi / K. Cheng, R. I. Mahato. – Wiley, - 2013. – 536 p.
    • Crowe S. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication, by Martínez et al. / S.Crowe // AIDS. – 2003. – Vol. 17, Suppl 4. – P. 103-105.
    • Cullen B.R. Does RNA interference have a future as a treatment for HIV-1 induced disease? / B.R. Cullen // AIDS Rev. – 2005. – Vol. 1. – P. 22-25.
    • Deeks S. G. Antiretroviral treatment of HIV infected adults / S.G. Deeks // BMJ. – 2006. – Vol. 332.
    • DiGiusto D.L. RNA-based gene therapy for HIV with lentiviral vector-modified CD34+cells in patients undergoing transplantation for AIDS related lymphoma / D.L. DiGiusto, A. Krishnan, L. Li [et al.] // Sci. Transl. Med. – 2010. Vol. 2, Issue 36. – P. 36-43.
    • Fire A. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans / A. Fire, SiQun Xu, M. K. Montgomery [et al.] // Nature. – 1998. – Vol. 391. – P. 806-811.
    • Fritz J.H. Innate immune defense through RNA interference / J.H.Fritz, S.E. Girardin, D.J. Philpott // Sci. STKE. – 2006. – Vol. 2006, Issue 339. – P. 27-30.
    • Hu L. Inhibition of measles virus multiplication in cell culture by RNA interference / L. Hu, Z. Wang, C. Hu [et al.] // Acta Virol. – 2005. – Vol. 49, № 4. – P. 227-234.
    • Huelsmann P.M. Inhibition of drug-resistant HIV-1 by RNA interference / P.M. Huelsmann, P. Rauch, K. Allers [et al.] // Antiviral Res. – 2006. – Vol. 69, № 1. – P. 1-8.
    • Jacque J.-M. Modulation of HIV-1 replication by RNA interference / J.-M. Jacque, K. Triques, M. Stevenson // Nature. – 2002. – Vol. 418. – P. 435-438.
    • Jiang M. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference / M. Jiang, J. Milner // Oncogene. – 2002. – Vol. 21, № 39. – P. 6041-6048.
    • Jia F. A retrovirus-based system to stably silence hepatitis B virus genes by RNA interference / F. Jia, C. Liu // Biotechnol. Lett. – 2006. – Vol. 28, № 20. – P. 1679-1685.
    • Kusov Y. Silencing of hepatitis A virus infection by small interfering RNAs / Y. Kusov, T. Kanda, A. Palmenberg [et al.] // J. Virol. – 2006. – Vol. 80, № 11. – P. 5599-5610.
    • Johnson V.A. Update of the drug resistance mutations in HIV-1: December 2009 / V.A. Johnson, F. Brun-Vezinet, B. Clotet [et al.] // Top HIV Med. – 2009. – Vol. 17, № 5. – P. 138-145.
    • Kumar P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice / P. Kumar, H.S. Ban, S.S. Kim [et al.] // Cell. – 2008. – Vol. 134, № 4. – P. 577-586.
    • Kuritzkes D. R. Drug resistance in HIV-1 / D. R. Kuritzkes // Cur. Opin. Virol. – 2011. – Vol. 1, № 6. – P. 582-589.
    • Li Y. Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus / Y. Li, L. Kong, B. Cheng [et al.] // Avian Dis. – 2005. – Vol. 549, № 4. – P. 562-573.
    • Li C.X. Delivery of RNA interference / C.X. Li, A. Parker, E.Menocal [et al.] // Cell Cycle. – 2006. – Vol. 5, № 18. – P. 2103-2109.
    • Liang M. Inhibition of HIV-1 infection by a unique short hairpin RNA to cheokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction / M. Liang, M. Kamata, K. N. Chen [et al.] // The Journal of Gene Medicine. – 2010. – Vol. 12, Issue 3. – P. 255-265.
    • Martínez M. A. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication / M. A. Martínez, A. Gutiérrez, M. Armand-Ugón // AIDS. – 2002. – Vol. 16, Issue 18. – P. 2385-2390.
    • Martinez M. A. RNA Interference and viruses: current innovations and future trends / M. A. Martinez // – Caister Academic Press, - 2010. – 252 p.
    • Maillard P.V. Antiviral RNA interference in mammalian cells / P.V. Maillard, C. Ciaudo, A. Marchais [et al.] // Science. - 2013. – Vol. 342, № 6155. – P. 235-238.
    • Orrell C. Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy / C. Orrell, J. Levison, A.Ciaranello // Pediatr Infect Dis J. – 2013. – Vol. 32, № 6. – P. 644-647.
    • Putral L. RNA interference for the treatment of cancer / L. Putral, W. Gu, N. McMillan // Drug News Perspect. – 2006. – Vol. 19, № 6. – P. 317-324.
    • Sah D. Therapeutic potential of RNA interference for neurological disorders / D. Sah // Life Sci. – 2006. – Vol. 79, № 19. – P. 1773-1780.
    • Sullenger B. A. Emerging clinical applications of RNA / B. A. Sullenger, E. Gilboa. // Nature. – 2002. – Vol. 418. – P. 252-258.
    • ter Brake O. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition / O. ter Brake, K. Hooft, Y. Po Liu [et al.] // Molecular Therapy. – 2008. – Vol. 16, №3. – P. 557-564.
    • ter Brake O. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2-/-γc-/-) mouse model / O. ter Brake, N. Legrand, K.J. von Eije [et al.] // Gene Therapy. – 2009. – Vol. 16. – P. 148-153.
    • The 2006 Nobel Prize in physiology or medicine. – Access mode: http://www.webcitation.org/61CfnnPLi.
    • Wolkowicz R. Gene therapy progress and prospects: Novel gene therapy approaches for AIDS / R. Wolkowicz, G.P. Nolan // Gene Therapy. - 2005. – Vol. 12. – P. 467-476.
    • Yamato K. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer / K. Yamato, T. Yamada, M. Kizaki // Cancer Gene Therapy. – 2008. – Vol. 15. – P. 140-153.
    Публикация статьи «Мир Медицины и Биологии» №2(49) 1 часть 2015 год, 192-195 страницы, код УДК [616.98:578.828:577.214/.217:575.116.1]-08